Thursday, July 31, 2014

Ann Bartlett's Posts

Google Gets into Diabetes Care with Smart Contact Lens

  Earlier this week, the news that was catching everyone’s attention was Google’s announcement that it had a new licensing deal with Novartis to bring its smart contact lens to the market. Among the ocular medical uses will be glucose monitoring and presbyopia.   The novel contact lens marries the electrochemical technology... Read moreChevron

Diabetes and the NIH

Continued from part 1: How NIH Came To Be   As NIH began to expand its grants program, they realized they needed more category institutes to appropriately focus their efforts, and this meant making a case to congress for more funding. Between 1946 and 1949, voluntary health organizations made the case for additional research on mental... Read moreChevron

FDA Approves Inhaled Insulin Afrezza

Alfred Mann has been working tirelessly for the diabetes community to make a painless way to take insulin.    Mann is an entrepreneur who has invested in biotechnology since the early 1970s. He is the developer of the cardiac pacemaker and the insulin pump (MiniMed). He also established Advanced Bionics, which manufactures... Read moreChevron

How the NIH Came to Be

For anyone living with a condition, like diabetes, advancement in medicine and technology is a lifeline to hope. Without medical and management advances, some of our friends with diabetes wouldn’t be with us, which is what makes the NIH an official ambassador of hope.   When I am looking to broaden my knowledge on a particular... Read moreChevron

Help Bring Timesulin to the US

I’ve talked about the important ingredient added to Novo Nordisk’s Echo Pen and Will DuBois was over the moon about it! <> But the flip side of this story is that we only have one insulin pen, in the US, that offers us a memory cap. And it works for only one type of insulin, which rapid acting insulin. So what about my flex pen... Read moreChevron